跳至主要内容
临床试验/JPRN-UMIN000006631
JPRN-UMIN000006631已完成1 期

Safety and efficacy of haploidentical hematopoietic stem-cell transplantation followed by post-transplant high-dose cyclophosphamide - Safety and efficacy of haploidentical hematopoietic stem-cell transplantation followed by post-transplant high-dose cyclophosphamide

niversity of Tsukuba, Department of Hematology0 个研究点目标入组 25 人开始时间: 2011年11月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with anti-HLA antibody 2) Patients with uncontrollable psychological complications 3) Patients with active double cancer 4) Patients with uncontrollable active infection 5) Pregnant women 6) Patients who are judged inappropriate by investigators

研究者

发起方
niversity of Tsukuba, Department of Hematology

相似试验